The detection of CAV1 and CAV2 in urine can be used to distinguish between CRPC and non-CRPC, and 12 urinary peptides have been found to be able to distinguish between prostate cancer and benign conditions [65]. The gene discussed is CAV2; the disease is prostate cancer.